BEAT Logo

HeartBeam, Inc. (BEAT) Insider Trading Activity

NASDAQ$1.55
Market Cap
$52.4M
Sector
Healthcare
Industry
Medical—Healthcare Information Services
Rank in Sector
306 of 877
Rank in Industry
13 of 38

BEAT Insider Trading Activity

BEAT Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$80,000
2
29
Sells
$28,045
5
71

Related Transactions

Ferrari Richarddirector
1
$50,000
0
$0
$50,000
Cruickshank TimCFO
1
$30,000
0
$0
$30,000
de Urioste Georgedirector
0
$0
5
$28,045
$-28,045

About HeartBeam, Inc.

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.

Insider Activity of HeartBeam, Inc.

Over the last 12 months, insiders at HeartBeam, Inc. have bought $80,000 and sold $28,045 worth of HeartBeam, Inc. stock.

On average, over the past 5 years, insiders at HeartBeam, Inc. have bought $90,353 and sold $60,448 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Ferrari Richard (director) — $50,000. Cruickshank Tim (CFO) — $30,000.

The last purchase of 29,412 shares for transaction amount of $50,000 was made by Ferrari Richard (director) on 2025‑02‑14.

List of Insider Buy and Sell Transactions, HeartBeam, Inc.

2025-02-14PurchaseFerrari Richarddirector
29,412
0.086%
$1.70
$50,000
-8.45%
2025-02-14PurchaseCruickshank TimCFO
17,647
0.0516%
$1.70
$30,000
-8.45%
2024-09-06Salede Urioste Georgedirector
1,674
0.0048%
$2.34
$3,917
-6.06%
2024-08-30Salede Urioste Georgedirector
5,500
0.0156%
$2.31
$12,705
-7.23%
2024-08-27Salede Urioste Georgedirector
2,194
0.0061%
$2.26
$4,958
-3.11%
2024-08-26Salede Urioste Georgedirector
300
0.0009%
$2.38
$714
-3.96%
2024-08-23Salede Urioste Georgedirector
2,500
0.007%
$2.30
$5,750
-7.23%
2023-09-29Salede Urioste Georgedirector
5,500
0.0139%
$2.06
$11,330
-3.26%
2023-09-28Salede Urioste Georgedirector
8,000
0.02%
$2.04
$16,320
+2.45%
2023-09-27Salede Urioste Georgedirector
1,834
0.0047%
$2.11
$3,870
-0.48%
2023-09-26Salede Urioste Georgedirector
5,000
0.0128%
$2.09
$10,450
-1.89%
2023-09-22Salede Urioste Georgedirector
2,393
0.0065%
$2.21
$5,289
-3.70%
2023-09-21Salede Urioste Georgedirector
100
0.0003%
$2.41
$241
-7.93%
2023-09-20Salede Urioste Georgedirector
883
0.0027%
$2.46
$2,172
-11.81%
2023-09-18Salede Urioste Georgedirector
5,000
0.0151%
$2.46
$12,300
-16.73%
2023-09-15Salede Urioste Georgedirector
4,269
0.0127%
$2.43
$10,374
-15.04%
2023-09-14Salede Urioste Georgedirector
5,000
0.0133%
$2.17
$10,850
-15.04%
2023-09-13Salede Urioste Georgedirector
5,000
0.0118%
$1.93
$9,656
+7.73%
2021-12-21PurchaseBROUNSTEIN RICHARD DChief Financial Officer
5,000
0.0206%
$3.37
$16,846
-51.25%
2021-11-11PurchaseBROUNSTEIN RICHARD DCHIEF FINANCIAL OFFICER
5,000
0.0367%
$5.99
$29,950
-62.58%
Total: 115
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
Ferrari Richarddirector
179136
0.5299%
$277,660.8010
de Urioste Georgedirector
57146
0.169%
$88,576.30016
Cruickshank TimCFO
17647
0.0522%
$27,352.8510
Guidant Investment CORP10 percent owner
787873
2.3305%
$1.22M01
Capper Joseph HPresident & CEO
178355
0.5276%
$276,450.251220
GORMAN KIRK Edirector
173315
0.5127%
$268,638.2546
PRYSTOWSKY ERIC Ndirector
125706
0.3718%
$194,844.3015
BROUNSTEIN RICHARD DChief Financial Officer
102075
0.3019%
$158,216.2520
<0.0001%
THURMAN RANDY HChairman, President & CEO
62536
0.185%
$96,930.8010
Broadway FredPresident BioTel Heart
24880
0.0736%
$38,564.00020
Ortigas-Wedekind Margadirector
16824
0.0498%
$26,077.2010
<0.0001%
GALVAN MARTIN PChief Financial Officer
11019
0.0326%
$17,079.4520
MIDDLETON FRED Adirector
8550
0.0253%
$13,252.5002
Ferola PeterSVP & General Counsel
8507
0.0252%
$13,185.85019
Sanderling Venture Partners IV, L.P.10 percent owner
2370
0.007%
$3,673.5001
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$1,129,324
21
20.33%
$88.87M
$1,034,521
17
-57.28%
$972.38M
$162,843,567
17
222.29%
$1.95B
$84,599
4
8.96%
$376.19M
HeartBeam, Inc.
(BEAT)
$100,706
3
-58.80%
$52.4M
$275,000
1
-4.39%
$9.19M

BEAT Institutional Investors: Active Positions

Increased Positions13+46.43%370,668+14.29%
Decreased Positions6-21.43%41,883-1.61%
New Positions5New132,950New
Sold Out Positions<1Sold Out23,919Sold Out
Total Postitions35+25%3M+12.67%

BEAT Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Vanguard Group Inc$1,382.002.25%763,703+12,989+1.73%2024-12-31
Smith Salley Wealth Management$665.001.08%367,647+117,647+47.06%2025-03-31
Geode Capital Management, Llc$438.000.71%241,839+8,442+3.62%2024-12-31
Ubs Group Ag$290.000.47%160,00200%2024-12-31
Ritholtz Wealth Management$252.000.41%139,18200%2025-03-31
O'shaughnessy Asset Management, Llc$252.000.41%139,18200%2024-12-31
Beacon Pointe Advisors, Llc$241.000.39%133,33400%2024-12-31
Kestra Private Wealth Services, Llc$189.000.31%104,346+725+0.7%2024-12-31
Stifel Financial Corp$181.000.29%100,00000%2024-12-31
Cannon Financial Strategists, Inc.$146.000.24%80,39100%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.